Oncology Peer Review On-The-Go: Amy Comander, MD, on SABCS Highlights and Key Breast Cancer Updates from 2021


In this episode of "Oncology Peer Review On-The-Go," Amy Comander, MD, spoke with CancerNetwork regarding important developments in breast cancer that took place in 2021 and key clinical trials that read out throughout the year.

After closing the book on the year 2021, CancerNetwork® spoke with Amy Comander, MD, co-medical director and director of breast oncology and cancer survivorship at Mass General Cancer Center, about some of the key developments and data to emerge throughout the year for patients with breast cancer. In particular, she homes in on studies featured at the 2021 San Antonio Breast Cancer Symposium (SABCS).

Not only did Comander detail important information that read out in 2021 for the breast cancer space, but she also touched on how the field is continuously evolving and shared her thoughts on what’s in store for patients in 2022.

Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify or anywhere podcasts are available.

Related Videos
Pegulicianine-guided breast cancer surgery may allow practices to de-escalate subsequent radiotherapy, says Barbara Smith, MD, PhD.
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer